Julian Harrison

Stock Analyst at BTIG

(0)
# 4262
Out of 5,243 analysts
55
Total ratings
42.86%
Success rate
-8.86%
Average return
24 Stocks
Name Action Price Target Current % Upside Ratings Updated
Avalo Therapeutics
Initiates Coverage On: Buy
40
6.08 557.89% 1 Dec 19, 2024
Cartesian Therapeuti...
Initiates Coverage On: Buy
42
18.5 127.03% 1 Dec 19, 2024
Keros Therapeutics
Downgrades: Neutral
n/a
n/a n/a 3 Dec 12, 2024
AnaptysBio
Downgrades: Neutral
n/a
n/a n/a 2 Dec 2, 2024
Outlook Therapeutics
Maintains: Buy
50 9
2.21 307.24% 5 Nov 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
8
2.47 223.89% 4 Nov 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
2.95 171.19% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
56 61
17.36 251.38% 3 Sep 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 15
4.58 227.51% 2 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
29 25
11.85 110.97% 3 Aug 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
41 51
38.12 33.79% 2 Jul 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 Jun 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
43
6.36 576.1% 1 May 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
32 40
21.73 84.08% 2 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
21
8.71 141.1% 1 Apr 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 8 Feb 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
43
40.42 6.38% 1 Dec 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
4
1.92 108.33% 1 Nov 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
150 150
0.59 25323.73% 1 Oct 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Sep 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
36
46.19 -22.06% 1 Mar 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
74 181
n/a n/a 3 Dec 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
4
n/a n/a 1 May 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 2 Feb 11, 2022